Intriguingly, γ-H2AX is now regarded as a useful biomarker for assessing radio sensitivity of cancer cells after treatment [23], and more recently, it was reported that this unique molecule might be increased in preneoplastic lesions such as colon adenoma [24] and dysplastic lesions in the bronchial epithelium [25]. This evidence concerns the gene H2AX and colon adenoma.